Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC (“RSAMMDA.LLC”) has closed on the acquisition of Protext Mobility, Inc TXTM in a share alternate whereby 100% of capital inventory in RSAMMDA.LLC will probably be exchanged for most popular inventory in Protext.
RSAMMDA.LLC. is a collectively owned firm centered on acquisitions with two principals, Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”) who signify the South African enterprise entities of RSAMMD and Leeds Boerdery. RSAMMD is a South African pioneer within the analysis, cultivation, manufacturing and distribution of medical hashish and cannabinoids. Leeds Boerdery, managed by Dr. J owns the 5000 Hectare New Fort Farm in addition to federally issued hashish and hemp licenses issued by the Authorities of South Africa.
RSAMMD administration has taken over the each day operations of Protext headed by Du Plooy as CEO and director, and Dr. Jamaloodeen as president and chairman of the board.
“This transaction has been a very long time within the making. For the previous couple years we now have been centered on constructing our operations in South Africa and globally, the place have constructed an in depth infrastructure and international hashish/hemp enterprise. Throughout this time period, we now have invested closely in constructing a major hashish/hemp operation to facilitate full seed to sale, R&D, international off-take agreements for finish product in addition to all of the extraction infrastructure wanted to create what we imagine to be a few of the highest high quality hemp and hashish on the planet. In South Africa proper now, we now have simply accomplished our semi-annual develop. RSAMMD in three way partnership with Leeds Boerdery, cultivated hemp and hashish crops this previous season on a mixed 1000+ hectares. All of that is finished below federally issued permits and licenses to develop, import/export hemp and hashish, in addition to analysis permits for conducting testing of ultimate merchandise for human consumption and medicinal advantages,” said Du Plooy.
“Over the coming days and weeks, we will be sharing our immediate term road map and long-term plans we are developing for Protext which should translate into increasing shareholder value. These plans include adding other valuable assets to the company which complement the core business, and executing on commercializing the proprietary live plant extraction technology as well as deploying our crypto platform, with a TXTM token which we are excited to rollout very soon.” concluded Du Plooy.”